Image credit: Merck. Pharmaceutical colossus Merck is ramping up the use and “widespread integration of data, digital, and analytics in all areas of our business.” That’s according to CEO Robert Davis on a July 30 earnings call, as Merck raised its full-year revenues outlook to $63.4 billion-$64.4 billion. Merck does not break out technology spending in its earnings. But the company earlier said it continues to move swathes of its IT infrastructure to the cloud, including a “ substantial portion ” to AWS as part of a migration being led by Accenture. (Like most multinationals Merck is “multi-cloud” and its life sciences business is a heavy GCP user, whilst its “ Merck Digital Sciences Studio ” relies significantly on Azure.) AI and drug discovery: Data access, quality remain hurdles Merck’s Chief Information & Digital Officer (CIDO) Dave Williams is leading that shift as part of a rolling enterprise digital transformation. Merck’s first Chief Science and Technology Officer Dr Laura Matz, meanwhile, who was appointed to the role in 2021, runs Merck’s tech-heavy global innovation hubs in China, Israel, Germany, and the US. Dr Matz, an analytical chemist by training, is overseeing initiatives that include work on “ digital chemistry […]
Click here to view original web page at www.thestack.technology
